Why the study?
Does lentiviral gene transfer efficiently transduce adult human peripheral blood-derived CD34+ NOD/SCID-repopulating cells?
Does lentiviral gene transfer efficiently transduce adult human peripheral blood-derived CD34+ NOD/SCID-repopulating cells?
Answers are grounded in this paper and cite their sources.
A lentiviral gene transfer protocol efficiently transduces adult human peripheral blood-derived CD34+ NOD/SCID-repopulating cells, demonstrating potential for clinical adaptation.
This study reports a lentiviral gene transfer protocol for efficient transduction of adult human peripheral blood (PB)-derived CD34+ NOD/SCID-repopulating cells (SRCs) using vesicular stomatitis virus-G protein (VSV-G)-pseudotyped lentiviruses encoding for enhanced green fluorescence protein (eGFP). Lentiviral stocks were concentrated by anion exchange chromatography, and transduction was performed under serum-free conditions at a multiplicity of infection (MOI) between 3 and 50. Similar transduction efficiencies were achieved in the presence and absence of cytokines. Transduction of PB-derived CD34+ cells at a MOI of 3 resulted in gene transfer efficiencies into SRCs of 9.2% and 12.0% in the absence and presence of cytokines, respectively. Using improved lentiviral vectors, transduction frequency varied between 42.0% (MOI 10) and 36.0% (MOI 50) with multilineage transgene expression within SRC-derived myeloid and lymphoid cells. The protocol described can be adapted for clinical application of lentiviral gene transfer into PB-derived CD34+ cells from adult patients.
No takes yet. Share an insight, caveat, or question.
Scherr et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: